Skip to main content

Advertisement

SpringerLink
Log in

Feasibility and response to 1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride chemotherapy with pre-treated procarbazine for elderly patients with newly diagnosed glioblastoma

  • Clinical – Patient studies
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the feasibility of 1-(4-amino- 2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of pre-treated procarbazine for elderly patients with newly diagnosed glioblastomas.

Patients and methods

From January 2004 to March 2005, 7 patients with glioblastoma were enrolled. After maximal surgical resection, patients were treated with two to four cycles of procarbazine (100 mg/m2 for day 1 to 5), ACNU (80 mg/m2/day1 for day 5), cepharantine (70 mg for day 5 and 12) and vincristine (1.4 mg/m2 for day 5 and 12).

Results

Significant toxicities of this regimen, including infectious toxicities, are described. Among the 7 patients enrolled, there were 6 patients were died, and one was still alive with disease at 13 months. The 6-month progression-free survival and 1-year overall survival are 29% (95% CI, 16% to 73%) and 29% (95% CI, 16% to 73%), respectively.

Conclusion

The chemotherapy regimen is active but too toxic for elderly patients with newly diagnosed glioblastoma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Devaux BC, O’Fallon JR, Kelly PJ (1993) Resection, biopsy, and survival in malignant glial neoplasms: a retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78:767–775

    Article  PubMed  CAS  Google Scholar 

  2. Davis FG, Freels S, Grutsch J, Barlas S, Brem S (1998) Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on surveillance, epidemiology, and end results (SEER) data, 1973–1991. J Neurosurg 88:1–10

    Article  PubMed  Google Scholar 

  3. Mohan DS, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH (1998) Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int Radiat Oncol Biol Phys 42:981–987

    Article  Google Scholar 

  4. Mangiola A, Maira G, De Bonis P, Porso M, Pettorini B, Sabatino G, Anile C (2006) Glioblastoma multiforme in the elderly: a therapeutic challenge. J Neurooncol 76:159–163

    Article  PubMed  Google Scholar 

  5. Valavanis C, Souliotis VL, Krytopoulos SA (1994) Differential effects of procarbazine and methylnitrosourea on the accumulation of O6-methylguanine and the depletion and recovery of O6-alkylguanine–DNA alkyltransferase in rat tissues. Carcinogenesis 15:1681–1688

    Article  PubMed  CAS  Google Scholar 

  6. Hirai M, Tanaka K, Shimizu T, Tanigawara Y, Yasuhara M, Hori R, Kakehi Y, Yoshida O, Ueda K, Komano T (1995) Cepharantin, a multidrug resistant modifier, is a substrate for p-glycoprotein. J Pharmacol Exp Ther 275:73–78

    PubMed  Google Scholar 

  7. Ogawa K, Yoshii Y, Inoue O, Toita T, Saito A, Kakinohana Y, Adachi G, Ishikawa Y, Kin S, Murayama S (2003) Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas. Radiother Oncol 67:63–67

    Article  PubMed  Google Scholar 

  8. Chinot OL, Barrie M, Frauger E, Dufour H, Figarella-Branger D, Palmari J, Braguer D, Hoang-Xuan K, Moktari K, Peragut JC, Martin PM, Grisoli F (2004) Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly population. Cancer 100:2208–2214

    Article  PubMed  CAS  Google Scholar 

  9. Pierga JY, Hoang-Xuan K, Feuvret L, Simon JM, Cornu P, Baillet F, Mazeron JJ, Delattre JY (1999) Treatment of malignant gliomas in the elderly. J Neuro Oncol 43:187–193

    Article  CAS  Google Scholar 

  10. Gilbert MR, Friedman HS, Kuttesch JF, Prados MD, Olson JJ, Reaman GH, Zaknoen SL (2002) A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neuro Oncol 4:261–267

    Article  PubMed  CAS  Google Scholar 

  11. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, Gardiman M, Scienza R, Monfardini S, Ermani M (2003) A prospective study on glioblastoma in the elderly. Cancer 97:657–662

    Article  PubMed  Google Scholar 

  12. Guyotat J, Signorelli F, Frappaz D, Madarassy G, Ricci AC, Bret P (2000) Is reoperation for recurrence of glioblastoma justified? Oncol Rep 7:899–904

    PubMed  Google Scholar 

  13. Grant R, Liang BC, Page MA, Crane DL, Greenberg HS, Junck L (1995) Age influences chemotherapy response in astrocytomas. Neurology 45:929–933

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan

    Mizuhiko Terasaki, Naohisa Miyagi & Minoru Shigemori

  2. Department of Radiology, Kurume University School of Medicine, Fukuoka, Japan

    Toshi Abe & Etsuyo Ogo

Authors
  1. Mizuhiko Terasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshi Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naohisa Miyagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Etsuyo Ogo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Minoru Shigemori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mizuhiko Terasaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Terasaki, M., Abe, T., Miyagi, N. et al. Feasibility and response to 1-(4-amino-2-methyl-5-pyrimidynyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride chemotherapy with pre-treated procarbazine for elderly patients with newly diagnosed glioblastoma. J Neurooncol 81, 265–269 (2007). https://doi.org/10.1007/s11060-006-9223-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-006-9223-0

Keywords

Search

Navigation